Your browser doesn't support javascript.
loading
Family Building in Transgender Patients: Modern Strategies with Assisted Reproductive Technology Treatment.
Ghofranian, Atoosa; Aharon, Devora; Friedenthal, Jenna; Hanley, William J; Lee, Joseph A; Daneyko, Margaret; Rodriguez, Zoe; Safer, Joshua D; Copperman, Alan B.
Afiliación
  • Ghofranian A; Department of Obstetrics, Gynecology, and Reproductive Science, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Aharon D; Department of Obstetrics, Gynecology, and Reproductive Science, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Friedenthal J; Reproductive Medicine Associates of New York, New York, New York, USA.
  • Hanley WJ; Department of Obstetrics, Gynecology, and Reproductive Science, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Lee JA; Reproductive Medicine Associates of New York, New York, New York, USA.
  • Daneyko M; Reproductive Medicine Associates of New York, New York, New York, USA.
  • Rodriguez Z; Reproductive Medicine Associates of New York, New York, New York, USA.
  • Safer JD; Reproductive Medicine Associates of New York, New York, New York, USA.
  • Copperman AB; Mount Sinai Center for Transgender Medicine and Surgery, New York, New York, USA.
Transgend Health ; 9(1): 76-82, 2024 Feb.
Article en En | MEDLINE | ID: mdl-38312448
ABSTRACT

Purpose:

Transgender and gender diverse (TGD) individuals continue to face adversity, stigma, and inequality, especially in health care. This study aimed to characterize the experience of TGD people and partners of TGD people with regard to fertility treatment.

Methods:

All TGD patients presenting to a single academic center between 2013 and 2021 were included. Baseline demographics collected included patient age, body mass index, anti-Mullerian hormone, basal antral follicle count, history of gender-affirming surgery, and/or gender-affirming hormone therapy. Outcomes included total patients who progressed to treatment, cycle type(s), and clinical outcomes.

Results:

In total, 82 patients who identified as TGD or had a partner who identified as TGD presented to care seeking fertility treatment. Of the 141 planned cycles, 106 (75.2%) progressed to treatment. Of the 15 in vitro fertilization (IVF) and co-IVF cycles, 12 achieved live birth. Of the 76 intrauterine inseminations 7 patients were discharged with ongoing pregnancies and one achieved live birth.

Conclusion:

These findings reaffirm that TGD individuals utilize the entire array of fertility services. With recent advances in access to care and modern medicine, assisted reproductive technology treatment has the power to support TGD patients in building contemporary family structures.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 Problema de salud: 1_medicamentos_vacinas_tecnologias / 2_cobertura_universal Tipo de estudio: Prognostic_studies Idioma: En Revista: Transgend Health Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 Problema de salud: 1_medicamentos_vacinas_tecnologias / 2_cobertura_universal Tipo de estudio: Prognostic_studies Idioma: En Revista: Transgend Health Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos
...